![Pieter van Rompay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 6 Mio $ am 31.05.2026
Pieter van Rompay has worked as a Director at EXO Biologics SA since 2019 and as a Managing Director & Director at Labo Phytophar NV since 2020.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Hyloris Pharmaceuticals SA
 Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs 3.72% | 31.12.2024 | 1’041’613 ( 3.72% ) | 6 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
EXO Biologics SA
 EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | 29.08.2019 |
Labo Phytophar NV
 Labo Phytophar NV Food: Specialty/CandyConsumer Non-Durables Manufactures medicaments, condiments and seasonings | Vorstandsvorsitzender | 30.10.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Labo Phytophar NV
Labo Phytophar NV Food: Specialty/CandyConsumer Non-Durables Manufactures medicaments, condiments and seasonings | Consumer Non-Durables |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
